Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

Wow! That is not chump change -

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
K The New Investor Member Profile
 
Followed By 1
Posts 13
Boards Moderated 0
Alias Born 07/28/16
160x600 placeholder
AstraZeneca, Merck Say Lynparza Demonstrates Long-Term Progression-Free Survival Benefit Dow Jones News - 9/18/2020 10:35:00 AM
LYNPARZA® (olaparib) Improved Median Progression-Free Survival to Over Four & a Half Years Compared to 13.8 Months with Plac... Business Wire - 9/18/2020 6:45:00 AM
PAOG Target CBD Pharma Development In Puerto Rico Could Get Boost From COVID-19 InvestorsHub NewsWire - 9/17/2020 12:31:38 PM
Vaccinex Shares Climb 18% on Keytruda Collaboration With Merck Dow Jones News - 9/17/2020 10:54:00 AM
Merck to Hold Investor Briefing Following ESMO Virtual Congress 2020 Business Wire - 9/16/2020 6:45:00 AM
BRENZYS® (injection d'étanercept) maintenant indiqué pour le traitement du psoriasis en plaques, du rhumatisme psoriasique... PR Newswire (Canada) - 9/15/2020 7:00:00 AM
BRENZYS® (etanercept injection) now indicated for the Treatment of Plaque Psoriasis, Psoriatic Arthritis and Juvenile Idiopa... PR Newswire (Canada) - 9/15/2020 7:00:00 AM
Merck to Present at the 2020 Cantor Fitzgerald Virtual Global Healthcare Conference Business Wire - 9/15/2020 6:45:00 AM
Merck Makes $1 Billion Deal -- WSJ Dow Jones News - 9/15/2020 3:02:00 AM
Merck to Invest $1 Billion in Seattle Genetics, Collaborate on Breast-Cancer Treatment Dow Jones News - 9/14/2020 7:38:00 AM
Seattle Genetics and Merck Announce Two Strategic Oncology Collaborations Business Wire - 9/14/2020 6:45:00 AM
Merck Covid-19 Vaccine Begins Human Testing--Update Dow Jones News - 9/11/2020 6:17:00 PM
Merck to Present at the Morgan Stanley 18th Annual Virtual Global Healthcare Conference Business Wire - 9/10/2020 6:45:00 AM
Merck: Phase 3 Studies of V114 Vaccine Meet Key Objectives Dow Jones News - 9/9/2020 7:40:00 AM
Merck Announces Positive Topline Results from Two Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent ... Business Wire - 9/9/2020 6:45:00 AM
Drug-Company CEOs Sign Pledge on Covid-19 Vaccine -- 2nd Update Dow Jones News - 9/8/2020 9:25:00 PM
Merck’s Gefapixant (45 mg Twice Daily) Significantly Decreased Cough Frequency Compared to Placebo at Week 12 & 24 in Patie... Business Wire - 9/8/2020 6:45:00 AM
Biopharma Leaders Unite to Stand with Science GlobeNewswire Inc. - 9/8/2020 6:30:10 AM
Biopharma Leaders Unite To Stand With Science Business Wire - 9/8/2020 6:30:00 AM
Biopharma Leaders Unite to Stand with Science Business Wire - 9/8/2020 6:30:00 AM
Merck to Present at the Citi 15th Annual BioPharma Virtual Conference Business Wire - 9/4/2020 6:45:00 AM
New Scientific Data at the ESMO Virtual Congress 2020 Reflect Merck’s Commitment to Advancing Cancer Research and Care Business Wire - 9/2/2020 6:45:00 AM
TriRx Pharmaceutical Services acquires MSD Animal Health manufacturing site located in Segré-en Anjou Bleu, France including... PR Newswire (US) - 9/1/2020 9:00:00 AM
Biotech Startup Yumanity Sets Reverse Merger With Proteostasis Dow Jones News - 8/24/2020 2:14:00 PM
Merck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan Business Wire - 8/24/2020 6:45:00 AM
K The New Investor   Tuesday, 08/16/16 08:23:18 AM
Re: DewDiligence post# 267
Post # of 557 
Wow! That is not chump change - even for the CEO's, I would say. Wonder what they know??? Or do they need to liquify for cash flow reasons?

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences